Nateglinide enhances the physiological insulin response to a meal in type 2 diabetics.

被引：0
|
作者：
McLeod, J
Hirschberg, Y
Garreffa, S
Keilson, L
Mather, S
机构：
[1] Novartis, E Hanover, NJ USA
[2] Maine Med Ctr, Portland, ME 04102 USA
[3] LeeCoast Res, Ft Myers, FL USA
来源：
DIABETOLOGIA | 1999年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
906
引用
收藏
页码：A241 / A241
页数：1
相关论文
共 50 条
  • [21] rhIGF-I improves glucose control in insulin-requiring type II diabetics.
    不详
    DIABETES, 1997, 46 : 582 - 582
  • [22] Increased insulin secretion and sympathetic activity in normal glucose tolerance offsprings of type II diabetics.
    Frontoni, S
    Farrace, S
    Caselli, A
    Barini, A
    Pellegrinotti, M
    DeAngelis, C
    Gambardella, S
    DIABETOLOGIA, 1997, 40 : 1761 - 1761
  • [23] Vitamin D Deficiency and Inflammatory Markers in African American Type 2 Diabetics.
    Villabona, C. V.
    Espinosa, I. M.
    Kazlauskaite, R.
    Barcham, S.
    Sevilleja-Smith, M. B.
    Miernik, J.
    Niklinski, W.
    Borgia, J. A.
    Fogelfeld, L.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [24] Beneficial effects of nateglinide on insulin resistance in type 2 diabetes
    Hazama, Y
    Matsuhisa, M
    Ohtoshi, K
    Gorogawa, S
    Kato, K
    Kawamori, D
    Yoshiuchi, K
    Nakamura, Y
    Shiraiwa, T
    Kaneto, H
    Yamasaki, Y
    Hori, M
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 71 (03) : 251 - 255
  • [25] Renal Function but not asymmetric Dimethylarginine is independently associated with Retinopathy in Type 2 Diabetics.
    Krzyzanowska, Katarzyna
    Mittermayer, Friedrich
    Schernthaner, Gerit-Holger
    Brunner, Simon
    Brix, Johanna
    Aschauer, Stefan
    Hoellerl, Florian
    Wolzt, Michael
    Schernthaner, Guntram
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 : S18 - S19
  • [26] Antioxidant defenses are reduced during meal in insulin-requiring type-2 diabetics the effect of insulin lispro
    Taboga, C
    Bortolotti, N
    Tonutti, L
    Lizzio, S
    Russo, A
    Santoro, D
    Ceriello, A
    DIABETOLOGIA, 1998, 41 : A242 - A242
  • [27] Antioxidant defenses are reduced during meal in insulin-requiring type-2 diabetics: the effect of insulin Lispro
    Ceriello, A
    Bortolotti, N
    Tonutti, L
    Lizzio, S
    Russo, A
    Santoro, D
    Taboga, C
    DIABETES, 1998, 47 : A351 - A351
  • [28] INSULIN RESISTANCE AND DECREASED INSULIN-RESPONSE TO GLUCOSE IN LEAN TYPE-2 DIABETICS
    WAJNGOT, A
    ROOVETE, A
    VRANIC, M
    LUFT, R
    EFENDIC, S
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (14): : 4432 - 4436
  • [29] Pharmacokinetics and pharmacodynamics of pulmonary insulin delivered via the AERx™ diabetes management system in Type 1 diabetics.
    Kipnes, M
    Otulana, B
    Okikawa, J
    Farr, S
    Jendle, J
    Thipphawong, J
    Schwartz, S
    DIABETOLOGIA, 2000, 43 : A201 - A201
  • [30] Pharmacodynamics and dose response of nateglinide in type 2 diabetes
    Hirschberg, Y
    McLeod, J
    Gareffa, S
    Spratt, D
    DIABETES, 1999, 48 : A100 - A100
12345